Navigation Links
Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures
Date:4/21/2008

rformance-based award of $150,000 in year three. Komen is funding $10.8 million in Career Catalyst Research grants for 2008.

Susan G. Komen for the Cure continues to offer Post-doctoral Fellowships to support training for investigators who are in the early stages of their research careers. With awards of up to $60,000 per year for two years and performance-based option for an additional $60,000 in year three, the awards are intended to attract new scientists to careers in breast cancer research. Komen for the Cure is funding just over $8 million in Post-doctoral Fellowship grants for 2008.

Komen for the Cure's scientific research portfolio continues to support Investigator Initiated Research projects by providing $600,000 per year for two to three years for the exploration of new ideas and approaches leading to reductions in breast cancer mortality and/or incidence within the next decade. Komen is investing more than $35 million in Investigator-initiated research grants for 2008.

Komen for the Cure also awarded a grant to the American Association of Clinical Oncology (ASCO) to create programs and provide grants that will support tangible improvements in access to and the delivery of cancer care, with special emphasis on addressing disparities in care and participation in clinical trials.

2007: Identifying, Funding Top Breast Cancer Priorities

Komen for the Cure's transition from funding a variety of largely investigator-initiated research projects to the funding of projects that fall within priority areas of focus began last year with funding of grants in four specific categories: ductal carcinoma in situ (DCIS), experimental model systems, identification and validation of bio-markers and the development of environmental research methods. Several 2007 Komen for the cure research awards have enabled researchers to focus their attention on key and growing areas of concern within the breast cancer research community. For example: '/>"/>

SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Susan G. Komen for the Cure Announces Recipients of 2007 Komen Brinker Award for Scientific Distinction
2. Cell Therapeutics, Inc. Announces Receipt of Letter From the NASDAQ Stock Market Regarding Non-Compliance With the Minimum Bid Price Requirement
3. US Oncology Announces Resignation of Chief Financial Officer
4. Biotherm Announces a Unique Dermobiotic Three-Step Anti-Cellulite Slimming Treatment
5. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
6. ARUP Laboratories CEO and Co-Founder Announces Retirement
7. Gene Network Sciences Names New CSO and Announces New Scientific Advisory Board
8. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
9. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
10. EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts
11. Angiotech announces director resignation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sig...ngattheNASDAQOMXconferenceonTuesday,December1stat1...listenvialiveaudiobroadcastovertheInternetavailabl... .Userscanclickthe"Webcast"icontoaccessthisfile. ...ngLifeScienceandHighTechnologycompany.Itschemicala...
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCal...alcompanyfocusedondevelopingandcommercializingnove...DiTonno,PresidentandChiefExecutiveOfficer,isschedu...onference,tobeheldDecember1-2,2009atTheNewYorkPala...enGhiglieri,ChiefFinancialOfficer,willbeavailablet...
(Date:11/24/2009)...,, ,Primaryefficacyendpointhasbeenmetforpatien... , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AE...ny"),aglobalbiopharmaceuticalcompanyfocusedonendoc...acydatafromaPhase2studywithitstargetedcytotoxicpep...ithadvancedorrecurrentendometrialcancer.Inapersona...
(Date:11/24/2009)...,, REDWOODCITY,Calif.,Nov.24/PRNewswire-First...ncedthatRandyScott,GenomicHealth,sExecutiveChairma...ConferenceinNewYorkCityonTuesday,December1,2009at1...chivedwebcastofthepresentation,visittheInvestorRel...estor.genomichealth.com .Pleaseconnecttothewebsite...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...essional hired to promote clinical awareness, ... BOSTON, MA and LIVINGSTON, Scotland, April 2 /PR... Hand, the world,s first commercially,available bi...ed that it,has hired Karl Lindborg, CPO, as the co...ediately, Lindborg will operate out of California,...
... April 2, 2008 ABR-Affinity,BioReagents, a leadin...at,it will exhibit for the first time at the 14th ...r Biomolecular Sciences (SBS) in St. Louis,April 6...t the advancement of the science of,drug discovery...t is a,non-profit forum. This is our first in what...
...Pharmaceutical,companies currently challenged with...ed to go off patent in the next four years must dr...cess, according to a new report,released by Deloit...nging Face of R&D in the Future,Pharmaceutical Lan..., current R&D,programs focused on developing a sma...
Other Biology Technology:Touch Bionics appoints Head of Clinical Advocacy 2ABR-Affinity BioReagents to Exhibit at the Society for Biomolecular Sciences in St. Louis, April 6 - 10, 2008 2As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report 2As Billions in Blockbuster Drug Revenue Goes Off Patent, Life Sciences Companies are Challenged to Fundamentally Change Future R&D Strategies, According to New Deloitte Report 3
(Date:11/25/2009)..., Dr. Sarit Larisch, Head of the Cell Death Rese...tment of Biology, has been awarded the prestigious...esearch exploring the cause of brain cell damage i... each year to scientists in support of innovation ...and officially conferred earlier this month at an ...
(Date:11/24/2009)... For thousands of years it has been prescribed by... ailments from headaches and stomach pain to fever...t Newcastle University have been able to scientifi...is crenata otherwise known as Brazilian mint. ,... the team led by researcher Graciela Rocha was abl...
(Date:11/24/2009)... The atomic-level action of a remarkable class of...researchers with the Lawrence Berkeley National La...rotein crystallography beamline at the Advanced Li...l roles in gene expression and replication, and ar...s well as infectious agents, such as the human pap...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Tyco International to Present at the Citi Industrial Manufacturing 26amp 3B Transportation Conference 60962 1intendiX Communication by Thoughts 3A First Patient Ready System on the Market 14766 1intendiX Communication by Thoughts 3A First Patient Ready System on the Market 14766 2AMD LASERS Names Dr James Jesse as Medical Director 6091 1AMD LASERS Names Dr James Jesse as Medical Director 6091 2
... When University of Illinois crop scientist Fred B...n grown in the tropics, he was looking for novel g...d was hoping to discover information that could be...er, it appears that maize itself may prove to be t...results show that tropical maize, when grown in th...
... BATON ROUGE In the jungles of Central and South...y of finding food by following hordes of army ant...ld, assistant curator of genetic resources at the ...sor of biological sciences, first witnessed this p...aduate student Ken Rosenberg to Peru as an assista...
... An ecologist at Washington University in St. Lou...drought in a region, when they revive, the communi...r to one another, like so many suburban houses mad...sociate professor of biology in Arts & Sciences, a...er, created 20 artificial ponds out of tanks that ...
Other Biology News:If corn is biofuels king, tropical maize may be emperor 2If corn is biofuels king, tropical maize may be emperor 3LSU professor studies army-ant-following birds 2After drought, ponds keep up with the Joneses 2After drought, ponds keep up with the Joneses 3
Rabbit Anti-Human Rab1A Antibody, Unconjugated from Spring Bioscience
Rat Anti-acetyl Salicylic Acid Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-DcR1 Monoclonal Antibody, Phycoerythrin Conjugated, Clone DJR3 from Abcam
Chicken Anti-GBL Polyclonal Antibody, Unconjugated from ProSci, Inc
Biology Products: